Different doses of intrathecal dexmedetomidine used as adjuvant to hyperbaric prilocaine
- Conditions
- Anaesthesia
- Registration Number
- PACTR202204558879194
- Lead Sponsor
- AFCM
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 69
•Adult patients (18-65 years).
•Both genders
•ASA I-II.
•Patients scheduled for elective surgeries under spinal anaesthesia.
•Patients with impaired mental status.
•Patients with body mass index <18 or > 35 kg/m2.
•Patients suffering from coagulation disorders.
•Patients with histories of allergic reactions to local anesthetics or dexmedetomidine.
•Patients suffering from severe cardiac, respiratory, hepatic, renal or neuropsychiatric disorders.
•Patients with histories of chronic use/abuse of sedatives, narcotics, and of alcohol or other drug abuse.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method